XML 93 R37.htm IDEA: XBRL DOCUMENT v3.23.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of provision for income taxes
Provision for income taxes consists of the following:
 
    
For the Year Ended December 31,
 
    
        2022        
    
        2021        
 
    
(in thousands)
 
Federal tax provision:
                 
Current
   $ 698      $ —    
Deferred
     —          —    
    
 
 
    
 
 
 
Total federal tax provision
     698        —    
State tax provision:
                 
Current
     17        —    
Deferred
     —          —    
    
 
 
    
 
 
 
Total state tax provision
     17        —    
    
 
 
    
 
 
 
Total tax provision
   $ 715      $ —    
    
 
 
    
 
 
 
Schedule of Reconciliation between U.S. Federal Statutory Tax Rate and Effective Tax Rate
A reconciliation between the U.S. federal statutory tax and the Company’s tax provision is summarized below. The Company has changed the presentation of its rate reconciliation from percentages to dollar amounts in the current year.
 
 
    
For the Year Ended December 31,
 
 
    
  2022  
 
  
  2021  
 
 
    
(in thousands)
 
Federal statutory tax
     $ (901    $ (20,111
Tax credits
       (13,955      (8,940
State taxes, net of federal tax benefit
       (2,994      (8,240
Non-deductible
expenses
       875        1,331  
Other
       1,410        (2,401
Change in valuation allowance
       16,280        38,361  
      
 
 
    
 
 
 
Tax provision
     $ 715      $ —    
      
 
 
    
 
 
 
Schedule of Deferred Tax Assets and Liabilities
The principal components of the Company’s deferred tax assets and liabilities consist of the following:
 
    
December 31,
 
    
2022
    
2021
 
    
(in thousands)
 
Deferred tax assets:
                 
Net operating losses
   $ 76,735      $ 100,417  
R&D credits
     66,761        51,705  
Equity compensation
     7,888        6,919  
Operating lease liabilities
     8,003        6,520  
Accrued expense and other
     1,479        2,072  
Deferred revenue
     314        1,189  
Capitalized R&D costs
     24,477        868  
    
 
 
    
 
 
 
Total deferred tax assets
     185,657        169,690  
 
    
December 31,
 
    
2022
    
2021
 
    
(in thousands)
 
Deferred tax liabilities:
                 
Right-of-use
assets
     (5,583      (4,252
Depreciation
     (171      (1,541
Other
     (251      (503
    
 
 
    
 
 
 
Total deferred tax liabilities
     (6,005      (6,296
    
 
 
    
 
 
 
Valuation allowance
     (179,652      (163,394
    
 
 
    
 
 
 
Net deferred taxes
   $ —        $ —    
    
 
 
    
 
 
 
Schedule of valuance allowance A roll forward of the valuation allowance is as follows:
 
    
Valuation
Allowance
 
    
(in thousands)
 
Balance at December 31, 2021
   $ (163,394
Utilization of net operating losses against taxable income
     23,654  
Increase in net deferred taxes
     (39,912
    
 
 
 
Balance at December 31, 2022
   $ (179,652